Clinical performance evaluation of a SARS-CoV-2 Rapid Antibody Test for determining past exposure to SARS-CoV-2

OBJECTIVES: Due to the number of asymptomatic infections and limited access to high-performance antibody tests, the true prevalence and seropositivity of SARS-CoV-2 infection remains unknown. To fill this gap, the clinical performance of a point-of-care SARS-CoV-2 Rapid Antibody Assay, a chromatogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Findeisen, Peter, Stiegler, Hugo, Lopez-Calle, Eloisa, Schneider, Tanja, Urlaub, Eva, Hayer, Johannes, Zemmrich, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677675/
https://www.ncbi.nlm.nih.gov/pubmed/33227517
http://dx.doi.org/10.1016/j.ijid.2020.11.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677675/
https://www.ncbi.nlm.nih.gov/pubmed/33227517
http://dx.doi.org/10.1016/j.ijid.2020.11.164

Ejemplares similares